300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Financial Services
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Wellness
Education
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Blockchain
Theatre
Software
Beauty
Fashion
Medical
Infrastructure
Social
Celebrity
Web3
Cannabis
LGBT
Climate
Food and Beverage
Recruiting
Real Estate
Sporting Goods
Music
Art
Life Science
Publishing
Wine and Spirits
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Mobile Apps
Enterprise
Community
Media (Entertainment)
Transportation
Biotech
Sustainability
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Faroe Islands
South Korea
Oceania
Hong Kong
Benin
Nigeria
Argentina
Togo
Croatia
Tunisia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Taiwan
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Zimbabwe
Nepal
Turkey
Pakistan
Liberia
Mexico
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
China
Guernsey
Cameroon
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
New Zealand
Cayman Islands
Venezuela
Myanmar
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Uganda
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Estonia
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Liechtenstein
Lebanon
Mongolia
Peru
Lithuania
Iceland
Cambodia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
David Fitzgerald, Managing Partner at Petra Capital Partners

David Fitzgerald

Managing Partner @ Petra Capital Partners

Nashville, United States

David Fitzgerald is a Series A investor at Petra Capital Partners in Nashville focused on Health Care and Medical. David Fitzgerald is based out of Nashville, Tennessee and is the Managing Partner of Petra Capital Partners. David previously worked at Three Oaks Hospice as a Board Member. David Fitzgerald attended the Washington and Lee University.

Total investments:
12
Last investment:
Lead investor:
50%

Last updated:

Industries David Fitzgerald invests in

Health CareMedicalHospitalBiotechnologyHealth Diagnostics

Stages David Fitzgerald invests in

Series AFunding RoundSeedSeries BSeries C

Countries David Fitzgerald invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 5 (42%)
  • Medical 3 (25%)
  • Hospital 3 (25%)
  • Biotechnology 3 (25%)
  • Health Diagnostics 2 (17%)
See all 17 industries →

Stage

  • Series A 3 (25%)
  • Funding Round 3 (25%)
  • Seed 1 (8%)
  • Series B 1 (8%)
  • Series C 1 (8%)
See all 7 stages →

Investments

CompanyDescriptionRoundLinks
American Vascular Associates' vision is to expand and support a synergistic model of outpatient solutions that is physician-driven and patient-focused. Private Equity / Apr 26, 2023
Urgent Team Holdings, Inc. operates urgent care centers that provide urgent and primary health care services. It offers services for patients in the areas of sprains, strains, and broken bones; muscular pain and injuries; eye irritation and eye injuries; cuts and scrapes; bites, stings, and allergic reactions; burns and infections; diarrhea,nausea, and vomiting; flu, colds, and viral illnesses; pneumonia and bronchitis; and asthma attacks. The company also offers preventative screenings/wellness services, including flu shots, physicals, immunization and vaccinations, EKGs, and osteoporosis screening, as well as blood glucose, blood pressure, and cholesterol checks; radiology, lab work and diagnostic testing, and drug and alcohol screening services; and services for employers. $18M / Series D / Oct 12, 2018
Kelly Klee is a digital insurance broker providing plans designed to cover important personal assets and wealth. Their service is engineered for busy professionals that wants a modern, technology-enabled solution for their personal insurance. Bob Klee and Jon Kelly established the firm in 2014 in Aspen, Colorado. $4.5M / Seed / Mar 08, 2018
Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which an individual's genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have asignificant positive impact. The company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS, and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world. $12.2M / Series C / Jan 26, 2015
Urgent Team Holdings, Inc. operates urgent care centers that provide urgent and primary health care services. It offers services for patients in the areas of sprains, strains, and broken bones; muscular pain and injuries; eye irritation and eye injuries; cuts and scrapes; bites, stings, and allergic reactions; burns and infections; diarrhea,nausea, and vomiting; flu, colds, and viral illnesses; pneumonia and bronchitis; and asthma attacks. The company also offers preventative screenings/wellness services, including flu shots, physicals, immunization and vaccinations, EKGs, and osteoporosis screening, as well as blood glucose, blood pressure, and cholesterol checks; radiology, lab work and diagnostic testing, and drug and alcohol screening services; and services for employers. $5.3M / Series B / May 21, 2014
Urgent Team Holdings, Inc. operates urgent care centers that provide urgent and primary health care services. It offers services for patients in the areas of sprains, strains, and broken bones; muscular pain and injuries; eye irritation and eye injuries; cuts and scrapes; bites, stings, and allergic reactions; burns and infections; diarrhea,nausea, and vomiting; flu, colds, and viral illnesses; pneumonia and bronchitis; and asthma attacks. The company also offers preventative screenings/wellness services, including flu shots, physicals, immunization and vaccinations, EKGs, and osteoporosis screening, as well as blood glucose, blood pressure, and cholesterol checks; radiology, lab work and diagnostic testing, and drug and alcohol screening services; and services for employers. $35M / Series A / Feb 15, 2012
Access Media 3 is led by a team of industry veterans that have identified a clear need for unparalleled service and commitment to the multi-dwelling unit market place (apartments, condominiums, retirement communities & off-campus student housing). $30M / Feb 09, 2012
Salveo Specialty Pharmacy® is an independent specialty pharmacy company that provides a wide array of medications and clinical services to patients with chronic conditions."Salveo" means to be well and in good health. Their purpose is to enhance and support the wellness and good health of each and every one of our patients. They workclosely with their customers, referral sources and insurance plans to facilitate the communication needed to achieve a superior level of patient care. Series A / Oct 13, 2011
Hospice is a program of care and support for a person diagnosed with a terminal illness and comfort care is desired. Helping people find meaning and peace is at the core of our mission.At New Century Hospice, our program supports early involvement where a dramatic difference in the quality of life can be experienced. By enabling families andloved ones to participate in the care experience, we are able to make the remaining time more meaningful, dignified and comfortable. $20M / Series A / Oct 14, 2010
Hospice is a program of care and support for a person diagnosed with a terminal illness and comfort care is desired. Helping people find meaning and peace is at the core of our mission.At New Century Hospice, our program supports early involvement where a dramatic difference in the quality of life can be experienced. By enabling families andloved ones to participate in the care experience, we are able to make the remaining time more meaningful, dignified and comfortable. $12M / Oct 12, 2010
See all 12 investments →

Co-Investors

Petra Capital Partners

About Petra Capital Partners

VC Fund · Nashville, United States

Petra Capital Partners is a Nashville, TN based private equity firm founded in 1996, engaged in providing growth capital for companies located throughout the United States. The partners of Petra have invested more than $650 million in 100 high growth private companies over the past 20 years. We are currently investing out of our third fund, closedin May 2013, with $230 million of available capital.We invest up to $20 million of our own capital per company. We are flexible in how we structure each investment to meet the needs of the owners and our own return objectives. We have invested in subordinated debt with warrants and equity securities. In addition to our own capital, Petra's limited partners are capable of providing additional capital in support of our portfolio companies.We are licensed as a Small Business Investment Company (SBIC) by the U.S. Small Business Administration, and was named SBIC of the Year in 2012.

Petra Capital Partners Contacts

NameEmailPhoneSocials
David Fitzgerald
David Fitzgerald Managing Partner
Carol Collins
Carol Collins Office Manager
Charles R. Webb
Charles R. Webb Associate
Douglas Owen
Douglas Owen Partner
Matthew S. Sotelo Associate

Sign up to unlock verified contacts

Unlock Contacts

See all 10 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Financial Services
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Wellness
Education
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Blockchain
Theatre
Software
Beauty
Fashion
Medical
Infrastructure
Social
Celebrity
Web3
Cannabis
LGBT
Climate
Food and Beverage
Recruiting
Real Estate
Sporting Goods
Music
Art
Life Science
Publishing
Wine and Spirits
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Mobile Apps
Enterprise
Community
Media (Entertainment)
Transportation
Biotech
Sustainability
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Faroe Islands
South Korea
Oceania
Hong Kong
Benin
Nigeria
Argentina
Togo
Croatia
Tunisia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Taiwan
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Zimbabwe
Nepal
Turkey
Pakistan
Liberia
Mexico
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
China
Guernsey
Cameroon
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
New Zealand
Cayman Islands
Venezuela
Myanmar
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Uganda
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Estonia
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Liechtenstein
Lebanon
Mongolia
Peru
Lithuania
Iceland
Cambodia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does David Fitzgerald invest in?

David Fitzgerald invests primarily in Health Care, Medical and Hospital startups, most often at Series A and Funding Round stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact David Fitzgerald?

Public channels for David Fitzgerald include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did David Fitzgerald last invest?

The most recent investment recorded for David Fitzgerald closed in Apr 2023. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
David Fitzgerald David Fitzgerald Find email